Sameh Aldesoky Anwar Lashen

• Dedicated and experienced internal medicine consultant, specialized in gastroenterology and endoscopy with +15 years of experience with proven track record of providing high-quality care to patients with a wide range of gastrointestinal disorders.
• Skilled in diagnosing and managing complex cases and working with interdisciplinary teams.
• Committed to staying updated with the latest advancements in the field, continuously improving clinical practice, and building strong relationships with patients, colleagues, and stakeholders to ensure exceptional healthcare services

• Place of Birth: Beheira, Egypt
• Citizenship: Egypt
• Date of Birth: 1982

• Y. Rostom, M.Y. El-Hasafy, A.S. El Yamany, and S.A. Lashen. Efficacy and Safety of 3-dimensional Conformal Radiation Therapy in Treatment of Portal Vein Thrombosis in Hepatocellular Carcinoma Patients. Int J Radiat Oncol Biol Phys 2012;84(3): S331.
• H. El Aggan, M. Helmy, L. Younis, E. Hassona, S. Lashen. Mammalian target of rapamycin (mTOR) and autophagy in hepatitis C virus-related hepatocellular carcinoma: relation to tumor progression. Ann of Onc 2015;26 (4): iv1-iv100.
• Lashen SA, Sanhoury MI. Syncope Following Sofosbuvir Therapy for Chronic Hepatitis C: A Report of Two Cases. J Liver Res Disord Ther2016; 2: 00032.
• HA EL Aggan, MA Helmy, LK Younis, EM Hassona, SA Lashen. Target of Rapamycin (TOR) and Autophagy in Chronic Hepatitis C Virus Infection: Relation to Disease Activity. J Liver Res Disord Ther 2017;3(3):63-72.
• Lashen SA, Shamseya MM, Madkour MA. Dynamic changes in aminotransferases in patients with chronic hepatitis C infection treated with direct acting antiviral drugs. Journal of Medical Research Institute 2017; 38(1):16-21.
• Lashen, SA, Shamseya, MM, Madkour, MA, Aboufarrag, GA. Tolerability and effectiveness of generic direct-acting antiviral drugs in eradication of hepatitis C genotype 4 among Egyptian patients. Liver Int. 2019; 39: 835-843.
• Kamal A, Elmoety AAA, Rostom YAM, Shater MS, Lashen SA. Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial. J Gastrointest Oncol. 2019;10(3):562-571.
• Lashen SA, Shamseya MM, Madkour MA. Hepatocellular Carcinoma Occurrence/Recurrence after Direct-Acting Antivirals for Hepatitis C in Egyptian Cohort: Single-Centre Experience. Dig Dis 2019; 37: 488-497.
• Ibrahim EH, Marzouk SA, Zeid AE, Lashen SA, Taher TM. Role of The von Willebrand Factor and The Vitro Score as Predictors for Variceal Bleeding In Patients With Hepatitis C-Related Cirrhosis. Eur J Gastroenterol Hepatol.2019 Feb;31(2):241-247.
• Lashen SA, Elshafei MM, Hablass FH, Alsayed EA, Hassan AA. Liver stiffness as a predictor of hepatocellular carcinoma behavior in patients with hepatitis C related liver cirrhosis. Hepatobiliary & Pancreatic Diseases International. 2020 Feb 1;19(1):22-8.
• Abdelaty TA, Morsy EY, El-Sayed ET, El-Rahmany SM, Lashen SA. Plasma microRNA-192 expression as a potential biomarker of diabetic kidney disease in patients with type 2 diabetes mellitus. Clin Diabetol 2020; Ahead of print.
• Elshaarawy O, Lashen SA, Makhlouf NA, Abdeltawab D, Zaghloul MS, Ahmed RM, et al. Barriers for resuming endoscopy service in the context of COVID-19 pandemic: A multicenter survey from Egypt. World J Gastroenterol 2020; In press.
• Lashen SA, Metawea MI, Shabaan A. Direct Antiviral Drugs in The Treatment of Hepatitis C-Infected Rheumatoid Arthritis Egyptian Cohort: Safety and Clinical Impact. Eur J Gastroenterol Hepatol. 2020; In press.
• Kamal A, Elmoety AAA, Rostom YA, Shater MS, Lashen SA. Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study. Clin Exp Hepatol. 2021;7(1):66-73.
• Hablass FH, Lashen SA, Mohamed EA. Liver Fibrosis Regression After Direct-Acting Antivirals for Hepatitis C Virus: A Prospective Study. Journal of Gastroenterology and Hepatology Research 2021; 10(1): 3429-3434.
• Makhlouf NA, Abdel-Gawad M, Mahros AM, Lashen SA, Zaghloul M, Eliwa A, et al. Colorectal cancer in Arab world: A systematic review. World J Gastrointest Oncol. 2021; 13(11):1791-1798.
• Lashen SA, Shamseya MM, Madkour MA, Abdel Salam RM, Mostafa SS. Β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study. World J Hepatol. 2022;14(2):429-441.
• M Abdel-Gawad, MS Zaghloul, S Abd-Elsalam, M Hashem, SA Lashen, et al. Post-COVID-19 Syndrome Clinical Manifestations: A Systematic Review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2022; 21:115-120.
• Hablass FH, Lashen SA, Alsayed EA. Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial. Turk J Gastroenterol. 2021 Sep;32(9):742-749.
• Walaa Sheba, Eman Morsy, Salah Altahan, Mona Ayaad & Sameh A.Lashen. Non-alcoholic fatty liver disease is associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes. Alexandria Journal of Medicine,2022; 58:1, 117-124.
• Said, Ebadaa; Abdel-Gawad, Muhammadb; Abdelsameea, Emanc; Elshemy, Eman Elsayedd; Abdeen, Nermeene; Elbasiony, Mohamedf; et al. Vibration Controlled Transient Elastography in Screening for Silent Liver Diseases. European Journal of Gastroenterology & Hepatology 35(10):p 1204-1210, October 2023.
• Hassafy, M.Y.E., Elhadidi, A.S., Tahoon, M.M. Hememi E, Lashen SA. Liver stiffness, hepatorenal index, and microRNA-130b as predictors for chronic kidney disease in patients with non-alcoholic fatty liver disease. Egypt Liver Journal 2023; 13, 37.
• Lashen SA, Shamseya MM, Shamseya AM, Hablass FH. Efficacy of Vonoprazan vs. Pantoprazole or Non-acid Suppression in Prevention of Post-variceal Ligation Ulcer Bleeding in Portal Hypertension: A Multi-arm Randomized Controlled Trial. J Clin Exper Hepatol 2023; 13; 962-971.

Well experienced medical statistical analysis ability, with a lot of published researches in prestigious international and indexed peer reviewed journals.